Controlled Reduction of Disulphide Bonds in Protein Therapeutics Using On-line EC–MS
Special Issues
Antec introduced the ROXY as an electrochemical reactor up-front MS. The electrochemically-assisted reduction of disulphide bonds followed by on-line mass spectrometric (MS) detection is presented.
Summary
Antec introduced the ROXY as an electrochemical reactor up-front MS. The electrochemically-assisted reduction of disulphide bonds followed by on-line mass spectrometric (MS) detection is presented. The method is based on square-wave potential pulses applied on a new type of proprietary working electrode made from titanium alloy. The method does not use any chemical agents and is purely instrumental, resulting in a fully automated platform for fast assessment and characterization of S–S bonds in proteins and peptides.
Figure 1: A schematic of a disulphide bond reduction: Replacing interfering chemicals (for example, DTT, TCEP) by an electrochemical reactor cell used on-line with LC–MS.
Reduction Efficiency
An electrochemical reactor offers an advantage over chemical reactions. By changing the applied potential, the extent of disulphide bond cleavage is controlled. More negative potentials result in a shift of the charge state distribution, thereby indicating increased disulphide bond cleavage and unfolding of the protein.
Figure 2: Partial and full reduction of disulphide bonds in α-lactalbumin. The overlapping isotopic pattern of the +9 ion measured with the EC reactor cell turned OFF (top), and ON at E1 = -1000 mV and E1 = -1300 mV.
Conclusion
- The chemical free EC reduction shows further great potential for disulphide bond reduction of TCEP-resistant proteins and peptides prior to hydrogen/deuterium exchange monitored MS (HDX–MS) analysis.
- The applied potential can be used to control the degree of S–S reduction.
- Fast reduction of S–S bonds in only a few seconds.
- Reagent and enzyme free.
- Ideal for TCEP-resistant proteins.
- ROXY can be used for on-line EC–MS or LC–EC–MS.
For a complete application note please visit our website www.myantec.com
Antec
Worldwide: Antec www.myantec.com
USA: Antec USA www.antec-hplc.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
